Article info

Download PDFPDF
General medicine
Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism

Authors

  • Lori-Ann Linkins Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Juravinski Hospital, Room A3-74, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Lori-Ann Linkins MD, MSc and FRCPC, Hematology, McMaster University Department of Medicine, Hamilton, Ontario L8S 4K1, Canada; linkinla{at}mcmaster.ca
View Full Text

Citation

Linkins L
Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism

Publication history

  • Received June 11, 2018
  • First published June 29, 2018.
Online issue publication 
November 21, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.